Dostinex, Tabletten

7680517560025 CH-51756 Tabletten
Dostinex, Tabletten
Dostinex, Tabletten
Dostinex, Tabletten
1 / 3
google

Article details

Package size
8
Selling units
8
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/04/2025
Patient information leaflet
Français
09/04/2025
Patient information leaflet
Italien
09/04/2025
Summary of Product Characteristics
Allemand
09/04/2025
Summary of Product Characteristics
Français
09/04/2025
Summary of Product Characteristics
Italien
09/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
leucinum
- Substance HNIDK
lactosum
75.9 MG Substance HBESI

Reimbursement information

Public price
CHF 52.30
Specialties list
Yes
Generic
No
SL addition date: 15/03/1996

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
51756
Drug name
Dostinex, Tabletten
Galenic form
TAB
ATC Code
G02CB03
Authorization status
Z
Dispensing category
B
First authorization
28/06/1995
Authorization expiration date
31/12/9999
IT Number
07.03.1.
Domain
Human medicine
Field of application
Hyperprolaktinämische Störungen, medizinisch indizierte Laktationshemmung

Package details

Description (FR)
DOSTINEX cpr 0.5 mg bte 8 pce
Description (DE)
DOSTINEX Tabl 0.5 mg Ds 8 Stk
Market launch
28/06/1995
Narcotic (BTM)
No

Other package sizes (3)

DOSTINEX cpr 0.5 mg bte 2 pce
2 TABL
GTIN: 7680517560018
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1